For only the second time since launching nearly two years ago, the AMR Action Fund has announced an investment in a fledgling biotech company as it tries to underwrite efforts to develop badly needed ...

LONDON – Twenty-three pharmaceutical companies are joining forces in the AMR Action fund and have raised $1 billion for the clinical development of antibiotic drugs addressing the most resistant ...

The antibiotics market is at risk of losing another decade to inadequate levels of research and innovation in favour of rare disease drugs, according to a new study. The antibiotics market is at risk ...

Antibiotic resistance poses one of the most important health challenges of the 21st century. And time has already run out to stop its dire consequences. I am a biochemist and microbiologist who has ...

A who’s who of Big Pharma companies, including Pfizer, Johnson & Johnson and Merck, has banded together to bolster the development of new antibiotics. The companies announced Thursday the $1 billion ...

Advanz Pharma secured rights to Polypid’s prolonged-release antibiotic candidate D-PLEX100, paying $2.6 million upfront and dangling more than $100 million in milestones to secure the European license ...

GlaxoSmithKline plans to shut down antibiotics production in the U.K. after wrapping up a $500 million product sale to Novartis’ Sandoz. GSK will finish out its supply commitment to Sandoz—a deal that ...

After decades of largely ignoring the antibiotics business, new research incentives from national governments are driving drugmakers to renew efforts to create new infection-fighting medicines, ...

Forget COVID-19, monkeypox, and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room ...

The microbes inside our bodies not only help break down food but also impact our health. Yet their precise influence is not ...

Antibiotic resistant bacteria are increasing. Overuse/misuse of antibiotics have had dire consequences. No new classes of antibiotics have been developed in almost 40 years. Significant new government ...

When scientists, public-health bodies and governments around the world warn that antimicrobial resistance is the next great health crisis, they have good reason. Since the 1960s, bacteria and other ...